BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Present at Upcoming Virtual Cell & Gene Meeting on the Mediterranean
Apr 5, 2021
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes, has announced that its COO and Executive VP, Michael Redman, will present at the annual Cell & Gene Meeting on the Mediterranean. The event is slated to take place virtually from April 6-9, 2021, with company presentations available for on-demand viewing throughout the entirety of the conference. Organized by the Alliance for Regenerative Medicine, the four-day virtual conference will feature more than 80 dedicated company presentations by leading public and private companies, highlighting recent technical and clinical achievements in the areas of cell therapy, gene therapy, gene editing, tissue engineering, and broader regenerative medicine technologies. The event also includes more than 50 panelists and featured speakers taking part in 13 in-depth sessions covering all aspects of cell and gene therapy commercialization.
To view the full press release, visit https://ibn.fm/cVxFX
About Genprex Inc.
Genprex is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. The company’s lead product candidate, “REQORSA(TM)” (quaratusugene ozeplasmid), is being evaluated as a treatment for non-small cell lung cancer (“NSCLC”). REQORSA has a multimodal mechanism of action that has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis, or programmed cell death, in cancer cells; and modulate the immune response against cancer cells. REQORSA has also been shown to block mechanisms that create drug resistance. In January 2020, the U.S. Food and Drug Administration granted Fast Track Designation for REQORSA for NSCLC in combination therapy with osimertinib (AstraZeneca’s Tagrisso(R)) for patients with EFGR mutations whose tumors progressed after treatment with osimertinib alone. For more information, visit the company’s web site at www.Genprex.com.
NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork
More News
NTF-Elcac scores groups criticizing BDP projects in Iloilo
MANILA, Philippines – The National Task Force to End Local Communist Armed Conflict (NTF-Elcac) has scored the “hypocrisy” of groups claiming to champion the poor while allegedly discrediting Iloilo’s Barangay Development Program (BDP). This came after Bayan-Panay, in a statement issued on Oct. 15, cited the Commission on Audit’s (COA) 2025 audit report on the
Kehlani live in Manila: Here are the ticket prices
Ticket details for Kehlani's upcoming concert at the SM Mall of Asia Arena on February 15, 2027 have been released.
/file/attachments/orphans/ZahidHamidi1_597968.png)
Court grants stay in M'sian Bar's challenge over Zahid case
Judge gives decision in chamber proceedings, lawyer says.
Rosal slightly accelerates; signal No. 1 still up in 6 areas
MANILA, Philippines — Tropical Cyclone Wind Signal No. 1 (TCWS) remained hoisted over six areas in northern and southern Luzon as Super Typhoon Rosal (international name: Champi) slightly accelerated over east of northern Luzon on Wednesday morning, according to the state weather bureau. In the 5 a.m. weather bulletin of the Philippine Atmospheric, Geophysical, and Astronomical
House panel summons DILG's Remulla, PDEA's Nerez over attempted Laos drugs shipment
The House Committee on Dangerous Drugs has summoned Interior and Local Government Secretary Jonvic Remulla and Philippine Drug Enforcement Agency (PDEA) Director General Undersecretary Isagani Nerez over the attempted shipment of illegal drugs from Laos.
Malaysia bans civil servants from using mapping app Waze, citing links to Israel
Prime Minister Anwar Ibrahim recommends the use of TuJu, a domestic mapping app developed by the Malaysian Highway Authority, as an alternative
Atong Ang out of PH? DOJ chief cannot confirm
Justice Secretary Fredderick Vida on Wednesday said he cannot confirm reports that businessman Atong Ang, the alleged mastermind in the disappearance of several sabungeros, has left the country.
5 ways to heal from a friendship breakup
If you’re navigating the grief and fallout of a difficult friendship breakup, here are a few ways to get by
New reality series helps Filipinos address skin conditions
“Kutis Reveal” follows 12 Filipinos through five months of consultations and treatment—hoping to improve not just their skin but also their confidence and quality of life
De Lima, Diokno, 8 other House lawmakers want China envoy recalled
The lawmakers say the President must 'take decisive action in response to statements and conduct that undermine national sovereignty and threaten the country's security'
Expectation vs. reality: Online seller's Chinese-style shirt ends up on horror character on 'Unang Hirit'
An online seller who posted his Chinese-style shirt on Facebook Marketplace got an unexpected surprise after finding out who actually wore the outfit.
Musk says SpaceX-Tesla merger is ‘a good idea’ as companies form deal committees
'I think it would be a good idea, but it's really up to the special committees of both companies,' Elon Musk says in the first official confirmation that the companies were formally talking
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.